# TB-500 FAQ: Safety, Steroid Question, BPC-157, and Status

> TB-500 questions answered from the research: side effects and the tumor signal, whether TB-500 is a steroid, the difference from BPC-157, long-term safety, and the FDA 503A and WADA status — each cited.

Direct answers on safety, the steroid question, BPC-157, and regulatory status — cited where the claim is quantitative.

## Identity and basics



## Safety and side effects



## Comparisons and status



## Research findings and efficacy



---

A soft-paneled research desk on the TB-500 and thymosin beta-4 literature — each finding set in its own panel, the fragment-versus-full-length caveat and the FDA 503A status pressed in before anything else, and no clinic, vendor, or prescription behind the surface.